CITADEL ADVISORS LLC

Q2 2022 13F-HR Detailed Holdings

Location
Chicago, IL
Holdings as of
6/30/2022
Date filed
8/15/2022
Form type
13F-HR
Num holdings
16,186
Total value ($000)
$389,708,921
Net value change ($000)
-94,744,073 (-19.6%)
New positions
1043
Sold out positions
1234
Turnover %
10.6%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
META 610,268 475.6%
LLY 365,807 3061.4%
HYG 275,515 501.4%
RMD 268,451 NEW
LULU 253,078 2371.9%
AMT 249,422 2437.4%
MSFT 234,504 204.7%
USB 215,363 10270.1%
TSCO 210,680 2060.2%
KHC 196,452 1378.5%
Top Reduces (Value $000, Stocks/ETFs)
SPY -646,681 -91.5%
PNC -438,393 -92.6%
ACN -427,385 -91.8%
FTV -403,965 -99.9%
T -399,400 -69.1%
IEMG -397,300 -92.3%
BKNG -328,645 -71.1%
GOOGL -327,595 -88.2%
TLT -320,547 -77.0%
JCI -306,745 -79.6%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 316,165,629 (81.1% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 Citadel Securities GP LLC 28-18870